| A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines P Ghasemiyeh, S Mohammadi-Samani, N Firouzabadi, A Dehshahri, ... International immunopharmacology 100, 108162, 2021 | 115 | 2021 |
| Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2 N Firouzabadi, P Ghasemiyeh, F Moradishooli, S Mohammadi-Samani International immunopharmacology 117, 109968, 2023 | 61 | 2023 |
| Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study E Bahramali, M Rajabi, J Jamshidi, SM Mousavi, M Zarghami, A Manafi, ... BMJ open 6 (2), e010282, 2016 | 56 | 2016 |
| Association of angiotensin-converting enzyme (ACE) gene polymorphism with elevated serum ACE activity and major depression in an Iranian population N Firouzabadi, M Shafiei, E Bahramali, SA Ebrahimi, H Bakhshandeh, ... Psychiatry research 200 (2-3), 336-342, 2012 | 53 | 2012 |
| SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease N Alimoradi, M Sharqi, D Firouzabadi, MM Sadeghi, MI Moezzi, ... Virology Journal 19 (1), 48, 2022 | 49 | 2022 |
| Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study N Firouzabadi, N Ghazanfari, A Alavi Shoushtari, N Erfani, F Fathi, ... PLoS One 11 (4), e0153667, 2016 | 34 | 2016 |
| Association of renin–angiotensin–aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: a case … E Bahramali, N Firouzabadi, M Rajabi, A Manafi, M Zarghami, ... Clinical and Experimental Hypertension 39 (4), 371-376, 2017 | 31 | 2017 |
| Association of angiotensin-converting enzyme polymorphism with coronary artery disease in Iranian patients with unipolar depression N Firouzabadi, N Tajik, E Bahramali, H Bakhshandeh, SA Ebrahimi, ... Clinical biochemistry 45 (16-17), 1347-1352, 2012 | 31 | 2012 |
| Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial E Bahramali, N Firouzabadi, I Yavarian, MRH Shayesteh, N Erfani, ... European journal of clinical pharmacology 72, 1059-1064, 2016 | 25 | 2016 |
| Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice MR Dorvash, MJ Khoshnood, H Saber, A Dehghanian, P Mosaddeghi, ... European Journal of Pharmacology 833, 165-172, 2018 | 21 | 2018 |
| The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns U Niroumand, N Firouzabadi, G Goshtasbi, B Hassani, P Ghasemiyeh, ... Frontiers in Materials 10, 1189463, 2023 | 20 | 2023 |
| Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs N Alimoradi, N Firouzabadi, R Fatehi Biomedicine & Pharmacotherapy 139, 111662, 2021 | 20 | 2021 |
| Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease N Firouzabadi, N Tajik, E Bahramali, H Bakhshandeh, M Maadani, ... Molecular biology reports 40, 4959-4965, 2013 | 20 | 2013 |
| Pharmacogenetic‐based management of depression: Role of traditional Persian medicine A Jalali, N Firouzabadi, MM Zarshenas Phytotherapy Research 35 (9), 5031-5052, 2021 | 19 | 2021 |
| Renin–angiotensin system genetic polymorphisms: Lack of association with CRP levels in patients with coronary artery disease E Bahramali, N Firouzabadi, N Jonaidi-Jafari, M Shafiei Journal of the Renin-Angiotensin-Aldosterone System 15 (4), 559-565, 2014 | 19 | 2014 |
| Interaction of A-240T and A2350G related genotypes of angiotensin-converting enzyme (ACE) is associated with decreased serum ACE activity and blood pressure in a healthy … N Firouzabadi, N Tajik, M Shafiei, SA Ebrahimi, H Bakhshandeh European journal of pharmacology 668 (1-2), 241-247, 2011 | 19 | 2011 |
| Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution R Fatehi, M Rashedinia, AR Akbarizadeh, N Firouzabadi Biochemical and Biophysical Research Communications 644, 130-139, 2023 | 18 | 2023 |
| Drug-based therapeutic strategies for COVID-19-infected patients and their challenges K Zarkesh, E Entezar-Almahdi, P Ghasemiyeh, M Akbarian, M Bahmani, ... Future microbiology 16 (18), 1415-1451, 2021 | 18 | 2021 |
| ncRNAs and polyphenols: new therapeutic strategies for hypertension E Shirazi-Tehrani, A Chamasemani, N Firouzabadi, M Mousaei RNA biology 19 (1), 575-587, 2022 | 17 | 2022 |
| How metformin affects various malignancies by means of microRNAs: a brief review N Alimoradi, N Firouzabadi, R Fatehi Cancer Cell International 21 (1), 207, 2021 | 17 | 2021 |
Soliman Mohammadi SamaniProfessor of Pharmaceutics, School of pharmacy, Shiraz University of Medical Sciences, Shiraz, IranVerified email at sums.ac.ir
